Cardiol Therapeutics Inc. (CRDL)

Cardiol Therapeutics Statistics

Total Valuation

CRDL has a market cap or net worth of $145.71 million. The enterprise value is $125.66 million.

Market Cap	145.71M
Enterprise Value	125.66M

Important Dates

The last earnings date was Monday, May 11, 2026, after market close.

Earnings Date	May 11, 2026
Ex-Dividend Date	n/a

Share Statistics

CRDL has 108.99 million shares outstanding. The number of shares has increased by 24.11% in one year.

Current Share Class	111.87M
Shares Outstanding	108.99M
Shares Change (YoY)	+24.11%
Shares Change (QoQ)	+11.28%
Owned by Insiders (%)	3.05%
Owned by Institutions (%)	11.38%
Float	93.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	8.40
P/TBV Ratio	8.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.39, with a Debt / Equity ratio of 0.00.

Current Ratio	4.39
Quick Ratio	3.93
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -173.96% and return on invested capital (ROIC) is -105.79%.

Return on Equity (ROE)	-173.96%
Return on Assets (ROA)	-78.25%
Return on Invested Capital (ROIC)	-105.79%
Return on Capital Employed (ROCE)	-146.60%
Weighted Average Cost of Capital (WACC)	6.58%
Revenue Per Employee	n/a
Profits Per Employee	-$1.45M
Employee Count	18
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +16.52% in the last 52 weeks. The beta is 0.43, so CRDL's price volatility has been lower than the market average.

Beta (5Y)	0.43
52-Week Price Change	+16.52%
50-Day Moving Average	1.29
200-Day Moving Average	1.11
Relative Strength Index (RSI)	47.66
Average Volume (20 Days)	420,029

Short Selling Information

The latest short interest is 1.97 million, so 1.80% of the outstanding shares have been sold short.

Short Interest	1.97M
Short Previous Month	1.98M
Short % of Shares Out	1.80%
Short % of Float	2.11%
Short Ratio (days to cover)	2.29

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-25.50M
Pretax Income	-26.04M
Net Income	-26.04M
EBITDA	-25.47M
EBIT	-25.50M
Earnings Per Share (EPS)	-$0.28

Balance Sheet

The company has $19.83 million in cash and $83,395 in debt, with a net cash position of $19.74 million or $0.18 per share.

Cash & Cash Equivalents	19.83M
Total Debt	83,395
Net Cash	19.74M
Net Cash Per Share	$0.18
Equity (Book Value)	17.34M
Book Value Per Share	0.16
Working Capital	17.29M

Cash Flow

In the last 12 months, operating cash flow was -$17.35 million and capital expenditures -$43,077, giving a free cash flow of -$17.64 million.

Operating Cash Flow	-17.35M
Capital Expenditures	-43,077
Depreciation & Amortization	28,853
Net Borrowing	-40,223
Free Cash Flow	-17.64M
FCF Per Share	-$0.16

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CRDL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.11%
Shareholder Yield	-24.11%
Earnings Yield	-17.87%
FCF Yield	-12.10%

Analyst Forecast

The average price target for CRDL is $7.36, which is 457.58% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.36
Price Target Difference	457.58%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2